| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -1% |
| 3Y CAGR | +71% |
| Profit growth | Value |
|---|---|
| 3Y CAGR | +34% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹3,781.10 -27.60 (0.72%) | 17,417.08 | 23.69 | 4.14 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,265.10 +6.30 (0.28%) | 17,194.23 | 25.36 | 5.1 | ||
Natco PharmaNATCOPHARM | ₹785.20 -15.65 (1.95%) | 15,708.15 | 13.72 | 1.5 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,063.50 +24.00 (0.40%) | 15,108.25 | 89.07 | 17.31 |